Diabetes, impaired fasting glucose, and heart failure: Its not all about the sugar

European Journal of Heart Failure

Volumn 16, Issue 11, 2014, Pages 1153-1156

  Sharma, Abhinav ^a   Ezekowitz, Justin A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; LIRAGLUTIDE; LONG ACTING INSULIN; METFORMIN; ROSIGLITAZONE; GLUCOSE BLOOD LEVEL;

CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; HEART FAILURE; HUMAN; IMPAIRED FASTING GLUCOSE; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; MALE; MORTALITY; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HUMANS; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84916595987     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.179     Document Type: Review

References (15)

1. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC,. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007; 154: 277.
2. Kannel WB, Hjortland M, Castelli WP,. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
3. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A,. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. JAC 2009; 54: 422-428.
4. Berry C, Brett M, Stevenson K, McMurray JJV, Norrie J,. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 2008; 94: 296-304.
5. Voors AA, van der Horst ICC,. Diabetes: a driver for heart failure. Heart 2011; 97: 774-780.
6. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN,. Meta-Analysis Global Group in Chronic Heart Failure. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013; 34: 1404-1413.
7. O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie BM,. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur J Heart Fail 2014; 14: 605-612.
8. Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, Olofsson S, Venge P, Larsson A, Hulthe J, Elmgren A, Wollert KC,. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Eur Heart J 2009; 30: 2346-2353.
9. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC,. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. JAC 2007; 50: 1054-1060.
10. Preiss D, Zetterstrand S, McMurray JJV, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N, for the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care 2009; 32: 915-920.
11. Go YY, Allen JC, Chia SY, Sim LL,. Predictors of mortality in acute heart failure: interaction between diabetes and impaired left ventricular ejection fraction. Eur J Heart Fail 2014; doi: 10.1002/ejhf.119.
12. Gotsman I, Shauer A, Lotan C, Keren A,. Impaired fasting glucose: a predictor of reduced survival in patients with heart failure. Eur J Heart Fail 2014; doi: 10.1002/ejhf.146.
13. The ORIGIN, Investigators T,. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367: 319-328.
14. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I,. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013; 369: 1317-1326.
15. Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA,. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34 000 patients. Circ Heart Fail 2013; 6: 395-402.